Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
KURA
#2246
Kura Oncology, Inc.
8.7
3
+4.30%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.30%
Monatliche Änderung
+3.44%
6 month change
+9.54%
Jahresänderung
+14.87%
Vorheriger Schlusskurs
8.3
7
Open
8.7
3
Bid
Ask
Low
8.7
3
High
8.7
3
Volumen
85
Märkte
Aktien
Gesundheitswesen
KURA
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
—
Valuation ratios
Enterprise value
1.84 B
841.93 M
772.88 M
1.13 B
478.91 M
2.09 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-13.62
Price to sales ratio
—
—
—
—
13.93
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
23.04
Price to book ratio
—
—
1.92
2.83
1.81
3.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.14
0.24
0.3
0.34
0.23
0.31
Return on equity %
0.15
0.26
0.32
0.38
0.42
0.73
Return on invested capital %
-4 731.27
-4 247.5
-4 669.95
-4 398.28
2 520.1
2 898.67
Gross margin %
—
100
—
—
100
—
Operating margin %
—
-61.81 K
—
—
358.55
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
61.54 K
—
—
322.89
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.49
23.26
18.56
12.26
9.46
28.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
—
—
0.09
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.08
Per share metrics
Operating cash flow per share
—
—
1.64
1.7
1.56
2.07
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
6.54
5.79
8.44
29.44
Net current asset value per share
—
—
6.66
5.91
8.64
31.55
Tangible book value per share
—
—
6.27
5.43
4.8
15.22
Working capital per share
—
—
6.3
5.42
7.73
27
Book value per share
—
—
6.27
5.43
4.8
15.22
Nachrichten
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Kura Oncology: Citizens sieht fast 200 % Kurspotenzial
Citizens reiterates Market Outperform rating on Kura Oncology stock
Kura Oncology’s chief legal officer sells $94,827 in stock
Kura Oncology: CCO verkauft Aktien im Wert von über 54.000 US-Dollar
Kura Oncology CCO Powl sells $54,266 in stock
Kura Oncology: Finanzchef verkauft Aktien im Wert von 60.000 US-Dollar
Kura Oncology SVP sells $60k in shares
Kura Oncology COO Ford sells $15,339 in stock
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock
Kura oncology CSO Burrows sells $11k in shares